Last reviewed · How we verify
NCT04649736: WAYRA
Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients
NA trial testing Respiratory and psychological rehabilitation in Covid19 in 108 participants. Completed in 19 June 2021.
19 June 2021
Quick facts
| Lead sponsor | Universidad Peruana Cayetano Heredia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 108 |
| Start date | 26 October 2020 |
| Primary completion | 19 June 2021 |
| Estimated completion | 19 June 2021 |
| Sites | 1 location across Peru |
Drugs / interventions tested
- Respiratory and psychological rehabilitation
Conditions studied
- Covid19 — all drugs for Covid19 →
- Respiratory Disease — all drugs for Respiratory Disease →
- Mental Health Disorder — all drugs for Mental Health Disorder →
Sponsor
Universidad Peruana Cayetano Heredia — full company profile →
Who can join
Adults 18 to 75, any sex, with Covid19 or Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Some COVID-19 survivors may have respiratory and mental health sequelae, especially those who required hospitalization. The investigators hypothesize that the participation of a rehabilitation program composite by home-based respiratory physiotherapy and telephone-based psychological support will improve respiratory function, quality of life, and psychological status in severe COVID-19 patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Home-Based Respiratory Physiotherapy and Telephone-Based Psychological Support for COVID-19 Survivors in Peru: Protocol for a Randomized Controlled Trial.
Soriano-Moreno AN, Flores EC, Hartinger SM, Mallma CY, et al · · 2022 · PMID 36108135 · DOI 10.2196/36001
Verify or expand the search:
- PubMed search for NCT04649736
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Universidad Peruana Cayetano Heredia trials
Trials by the same sponsor.
- NCT06367361 — One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis · Phase 2 · not yet recruiting
- NCT06989502 — Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries · NA · not yet recruiting
- NCT06565507 — Oxfendazole in Mild Parenchymal Brain Cysticercosis · Phase 2, PHASE3 · not yet recruiting
- NCT05981378 — Genomic Approaches to Dissect Human Host-pathogen Interactions in the Amazonian Rainforest · not yet recruiting
- NCT06500013 — WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People With HIV in Peru · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04649736 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Peruana Cayetano Heredia
- Last refreshed: 3 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04649736.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing